# J&A Partners

J&A Partners is a Single Family Office based in Scottsdale, United States.

## Overview

- **Organization type:** Single Family Office
- **Headquarters:** Scottsdale, United States
- **Region:** North America
- **Address:** Scottsdale, AZ, United States
- **Assets under management:** Undisclosed
- **Website:** japartners.ch
- **LinkedIn:** https://ch.linkedin.com/company/japartnersag

## Regulatory record

- **Reports private funds:** No

## About

Ramesh Juneja founded J&A Partners as the single-family investment vehicle for the wealth generated through Mankind Pharma, the Indian drugmaker he built into one of the country's largest by prescription base. The Scottsdale-headquartered office is guided by principals Rajeev Juneja and Arjun Juneja, both senior Mankind Pharma operators, cementing the link between the family's operating business and its investment platform. The firm extends beyond the pharmaceutical brand by committing to direct stakes in early-stage and late-stage companies. Its focus areas include Digital Health, Healthcare Services, PropTech, and FinTech, with a geographic footprint concentrated on the Asian market. J&A Partners structures its commitments through direct co-investments and special-purpose vehicles, often alongside frequent partner Dinesh Mody Ventures. Confirmed technology lenses include AI/ML and Edge & IoT applications within its sector verticals. The principals participate in the Young Presidents' Organization network, which can serve as a deal-discovery channel among peer operators and high-net-worth families. The family's philanthropic activity is housed formally under the Mankind Pharma Foundation, creating a separate legal conduit for charitable capital. No external figure for total deployment or team headcount is publicly available. Structural differentiation lies in the embedded operational DNA: the family office does not outsource sector expertise to external consultants in pharmaceutical-adjacent verticals but instead draws on the executive team of Mankind Pharma — where Rajeev Juneja serves as Vice Chairman and Managing Director and Arjun Juneja as COO — creating a sourcing advantage for drug-delivery, healthtech, and adjacent supply-chain investments.

## Sectors

- Digital Health
- Healthcare Services
- PropTech
- Sports & Wellness
- FinTech
- Supply Chain & Logistics
- ClimateTech

## People

- Ramesh Juneja — Founder and Chairman
- Rajeev Juneja — Vice Chairman and Managing Director
- Arjun Juneja — Chief Operating Officer
- Sheetal Arora — CEO

## Questions

### Who runs investment decisions at J&A Partners?

Ramesh Juneja serves as founder and chairman. Rajeev Juneja and Arjun Juneja hold operating roles that extend from Mankind Pharma into the family office.

### How does J&A Partners source proprietary deal flow?

Deal flow arrives through co-investment relationships such as Dinesh Mody Ventures and through the principals' operating network at Mankind Pharma.

### Is J&A Partners structured as a single family office or does it operate more like a venture firm?

It functions as a single family office that executes direct co-investments and SPVs rather than maintaining external fund commitments.

### What investment stages does J&A Partners typically target?

The firm targets early-stage and late-stage opportunities.

### Does J&A Partners maintain philanthropic structures, and how are they separated?

The Mankind Pharma Foundation handles philanthropic activity separately from the investment office.

### What is J&A Partners' known posture on co-investments alongside external GPs?

The firm participates in direct co-investments and maintains recurring partnerships such as Dinesh Mody Ventures.

## Related profiles

- [Heritage Highland Finance & Management Service](https://altss.com/profile/heritage-highland-finance-and-management-service)
- [J.S. Bean & Son](https://altss.com/profile/js-bean-and-son)

---

Last updated: 2026-08-10T15:54:10.904Z

Canonical page: https://altss.com/profile/janda-partners-family-office

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology